Application of a modified sequential organ failure assessment score to critically ill patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Medical and Biological Research |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186 |
Resumo: | The purpose of the present study was to explore the usefulness of the Mexican sequential organ failure assessment (MEXSOFA) score for assessing the risk of mortality for critically ill patients in the ICU. A total of 232 consecutive patients admitted to an ICU were included in the study. The MEXSOFA was calculated using the original SOFA scoring system with two modifications: the PaO2/FiO2 ratio was replaced with the SpO2/FiO2 ratio, and the evaluation of neurologic dysfunction was excluded. The ICU mortality rate was 20.2%. Patients with an initial MEXSOFA score of 9 points or less calculated during the first 24 h after admission to the ICU had a mortality rate of 14.8%, while those with an initial MEXSOFA score of 10 points or more had a mortality rate of 40%. The MEXSOFA score at 48 h was also associated with mortality: patients with a score of 9 points or less had a mortality rate of 14.1%, while those with a score of 10 points or more had a mortality rate of 50%. In a multivariate analysis, only the MEXSOFA score at 48 h was an independent predictor for in-ICU death with an OR = 1.35 (95%CI = 1.14-1.59, P < 0.001). The SOFA and MEXSOFA scores calculated 24 h after admission to the ICU demonstrated a good level of discrimination for predicting the in-ICU mortality risk in critically ill patients. The MEXSOFA score at 48 h was an independent predictor of death; with each 1-point increase, the odds of death increased by 35%. |
id |
ABDC-1_dfef8b026d1ba9920fdda641248dba2f |
---|---|
oai_identifier_str |
oai:scielo:S0100-879X2013000200186 |
network_acronym_str |
ABDC-1 |
network_name_str |
Brazilian Journal of Medical and Biological Research |
repository_id_str |
|
spelling |
Application of a modified sequential organ failure assessment score to critically ill patientsSequential organ failure assessment scoreOrgan dysfunctionCritically ill patientsMortalityIntensive care unit survivalMEXSOFAThe purpose of the present study was to explore the usefulness of the Mexican sequential organ failure assessment (MEXSOFA) score for assessing the risk of mortality for critically ill patients in the ICU. A total of 232 consecutive patients admitted to an ICU were included in the study. The MEXSOFA was calculated using the original SOFA scoring system with two modifications: the PaO2/FiO2 ratio was replaced with the SpO2/FiO2 ratio, and the evaluation of neurologic dysfunction was excluded. The ICU mortality rate was 20.2%. Patients with an initial MEXSOFA score of 9 points or less calculated during the first 24 h after admission to the ICU had a mortality rate of 14.8%, while those with an initial MEXSOFA score of 10 points or more had a mortality rate of 40%. The MEXSOFA score at 48 h was also associated with mortality: patients with a score of 9 points or less had a mortality rate of 14.1%, while those with a score of 10 points or more had a mortality rate of 50%. In a multivariate analysis, only the MEXSOFA score at 48 h was an independent predictor for in-ICU death with an OR = 1.35 (95%CI = 1.14-1.59, P < 0.001). The SOFA and MEXSOFA scores calculated 24 h after admission to the ICU demonstrated a good level of discrimination for predicting the in-ICU mortality risk in critically ill patients. The MEXSOFA score at 48 h was an independent predictor of death; with each 1-point increase, the odds of death increased by 35%.Associação Brasileira de Divulgação Científica2013-02-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186Brazilian Journal of Medical and Biological Research v.46 n.2 2013reponame:Brazilian Journal of Medical and Biological Researchinstname:Associação Brasileira de Divulgação Científica (ABDC)instacron:ABDC10.1590/1414-431X20122308info:eu-repo/semantics/openAccessÑamendys-Silva,S.A.Silva-Medina,M.A.Vásquez-Barahona,G.M.Baltazar-Torres,J.A.Rivero-Sigarroa,E.Fonseca-Lazcano,J.A.Domínguez-Cherit,G.eng2015-10-08T00:00:00Zoai:scielo:S0100-879X2013000200186Revistahttps://www.bjournal.org/https://old.scielo.br/oai/scielo-oai.phpbjournal@terra.com.br||bjournal@terra.com.br1414-431X0100-879Xopendoar:2015-10-08T00:00Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC)false |
dc.title.none.fl_str_mv |
Application of a modified sequential organ failure assessment score to critically ill patients |
title |
Application of a modified sequential organ failure assessment score to critically ill patients |
spellingShingle |
Application of a modified sequential organ failure assessment score to critically ill patients Ñamendys-Silva,S.A. Sequential organ failure assessment score Organ dysfunction Critically ill patients Mortality Intensive care unit survival MEXSOFA |
title_short |
Application of a modified sequential organ failure assessment score to critically ill patients |
title_full |
Application of a modified sequential organ failure assessment score to critically ill patients |
title_fullStr |
Application of a modified sequential organ failure assessment score to critically ill patients |
title_full_unstemmed |
Application of a modified sequential organ failure assessment score to critically ill patients |
title_sort |
Application of a modified sequential organ failure assessment score to critically ill patients |
author |
Ñamendys-Silva,S.A. |
author_facet |
Ñamendys-Silva,S.A. Silva-Medina,M.A. Vásquez-Barahona,G.M. Baltazar-Torres,J.A. Rivero-Sigarroa,E. Fonseca-Lazcano,J.A. Domínguez-Cherit,G. |
author_role |
author |
author2 |
Silva-Medina,M.A. Vásquez-Barahona,G.M. Baltazar-Torres,J.A. Rivero-Sigarroa,E. Fonseca-Lazcano,J.A. Domínguez-Cherit,G. |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Ñamendys-Silva,S.A. Silva-Medina,M.A. Vásquez-Barahona,G.M. Baltazar-Torres,J.A. Rivero-Sigarroa,E. Fonseca-Lazcano,J.A. Domínguez-Cherit,G. |
dc.subject.por.fl_str_mv |
Sequential organ failure assessment score Organ dysfunction Critically ill patients Mortality Intensive care unit survival MEXSOFA |
topic |
Sequential organ failure assessment score Organ dysfunction Critically ill patients Mortality Intensive care unit survival MEXSOFA |
description |
The purpose of the present study was to explore the usefulness of the Mexican sequential organ failure assessment (MEXSOFA) score for assessing the risk of mortality for critically ill patients in the ICU. A total of 232 consecutive patients admitted to an ICU were included in the study. The MEXSOFA was calculated using the original SOFA scoring system with two modifications: the PaO2/FiO2 ratio was replaced with the SpO2/FiO2 ratio, and the evaluation of neurologic dysfunction was excluded. The ICU mortality rate was 20.2%. Patients with an initial MEXSOFA score of 9 points or less calculated during the first 24 h after admission to the ICU had a mortality rate of 14.8%, while those with an initial MEXSOFA score of 10 points or more had a mortality rate of 40%. The MEXSOFA score at 48 h was also associated with mortality: patients with a score of 9 points or less had a mortality rate of 14.1%, while those with a score of 10 points or more had a mortality rate of 50%. In a multivariate analysis, only the MEXSOFA score at 48 h was an independent predictor for in-ICU death with an OR = 1.35 (95%CI = 1.14-1.59, P < 0.001). The SOFA and MEXSOFA scores calculated 24 h after admission to the ICU demonstrated a good level of discrimination for predicting the in-ICU mortality risk in critically ill patients. The MEXSOFA score at 48 h was an independent predictor of death; with each 1-point increase, the odds of death increased by 35%. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-02-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2013000200186 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1414-431X20122308 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research v.46 n.2 2013 reponame:Brazilian Journal of Medical and Biological Research instname:Associação Brasileira de Divulgação Científica (ABDC) instacron:ABDC |
instname_str |
Associação Brasileira de Divulgação Científica (ABDC) |
instacron_str |
ABDC |
institution |
ABDC |
reponame_str |
Brazilian Journal of Medical and Biological Research |
collection |
Brazilian Journal of Medical and Biological Research |
repository.name.fl_str_mv |
Brazilian Journal of Medical and Biological Research - Associação Brasileira de Divulgação Científica (ABDC) |
repository.mail.fl_str_mv |
bjournal@terra.com.br||bjournal@terra.com.br |
_version_ |
1754302942019584000 |